Trexbio completes $26 million series a extension led by polaris partners to advance treatments for immune-mediated diseases

South san francisco, calif.--(business wire)-- #biotech--trexbio has completed a $26 million extension of its series a financing in a round led by new investor polaris partners.
PII Ratings Summary
PII Quant Ranking